Urogen Pharma (URGN)
NASDAQ:URGN
Holding URGN?
Track your performance easily

Urogen Pharma (URGN) Financial Statements

437 Followers

Urogen Pharma Financial Overview

Urogen Pharma's market cap is currently ―. The company's EPS TTM is $-3.271; its P/E ratio is -4.14; Urogen Pharma is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 21.85M$ 18.78M$ 23.53M$ 20.85M$ 21.14M
Gross Profit$ 19.62M$ 17.05M$ 21.24M$ 18.48M$ 18.70M
EBIT$ -29.90M$ -29.79M$ -14.61M$ -18.07M$ -20.32M
EBITDA$ -29.23M$ -29.43M$ -14.56M$ -17.39M-
Net Income Common Stockholders$ -33.40M$ -32.29M$ -26.02M$ -21.88M$ -24.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 241.08M$ 164.04M$ 136.97M$ 147.42M$ 48.12M
Total Assets$ 281.85M$ 200.57M$ 178.31M$ 193.63M$ 95.36M
Total Debt$ 98.24M$ 98.23M$ 99.39M$ 99.54M$ 99.50M
Net Debt$ -142.84M$ -65.82M$ -37.57M$ -47.88M$ 51.39M
Total Liabilities$ 251.53M$ 240.71M$ 243.52M$ 235.63M$ 233.79M
Stockholders Equity$ 30.31M$ -40.13M$ -65.21M$ -41.99M$ -138.43M
Cash Flow-
Free Cash Flow$ -23.83M$ -31.73M$ -13.05M$ -17.40M-
Operating Cash Flow$ -23.75M$ -31.73M$ -13.00M$ -17.30M-
Investing Cash Flow$ 12.00M$ 13.52M$ -11.34M$ 401.00K-
Financing Cash Flow$ 100.28M$ 54.66M$ 40.00K$ 116.08M-
Currency in USD

Urogen Pharma Earnings and Revenue History

Urogen Pharma Debt to Assets

Urogen Pharma Cash Flow

Urogen Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis